COVID-19 News & Education
Latest articles from our blog
BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19.Read more »
View our latest news about advancements in health science, COVID-19, and more.
Labcorp's COVID-19 PCR Testing
Average Time to Result from Specimen Pickup
Molecular tests performed
Molecular test capacity per day**
Antibody tests performed
Antibody test capacity per day**
Tests Offered with No Upfront Costs*
Stats updated as of July 31, 2021. COVID-19 volumes are U.S. only. Future COVID-19 test volumes will be updated quarterly after the release of Labcorp’s quarterly earnings results.
*A $10 non-refundable physician fee is charged for the IgG antibody test if it is requested through Labcorp.com
**Capacity numbers are subject to sufficient equipment and supplies
Tracking COVID-19 Variants
We have been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants.
Labcorp PCR Test Performance Confirmed
Variant B.1.1.7 (Alpha, Common name: U.K. Variant)
Variant B.1.351 (Beta Common name: South Africa Variant)
Variant P.1 (Gamma, Common name: Brazil Variant)
Variant B.1.526 (Iota, Common name: New York Variant)
Variant B.1.617.2 (Delta, Common name: India Variant)
Variant C.37 (Lambda, Common name: Peru Variant)
Labcorp has been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.
For more information visit US COVID-19 Cases Caused by Variants on the CDC website.
Data covers the U.S. including the District of Columbia and Puerto Rico.
Total number of samples sequenced: 70,000 (as of July 2, 2021)